NCT01783587 Safety Study of Afatinib and Postoperative Radiation Therapy to Treat Head and Neck Cancer Status COMPLETED Phase PHASE1
NCT01761747 Ponatinib for Squamous Cell Lung and Head and Neck Cancers Status TERMINATED Phase PHASE2/PHASE3
NCT01754389 Standard of Care vs. Bortezomib in Graft-Versus Host Disease After Hematopoietic Stem Cell Transplant Status COMPLETED Phase PHASE2
NCT01747551 FOLFOX +/- Ziv-Aflibercept for Esophageal and Gastric Cancer Status COMPLETED Phase PHASE2
NCT01740219 Promoting Organizational Capacity to Implement Cancer Control Programs Among Latino Churches Status COMPLETED Phase NA
NCT01711632 BRAF Inhibitor, Vemurafenib, in Patients With Relapsed or Refractory Hairy Cell Leukemia Status COMPLETED Phase PHASE2
NCT01664091 Cosmetic Result/Toxicity in Post-Mastectomy Immediate Reconstruction Expander+RT Status COMPLETED Phase NA
NCT01664000 A Safety, Pharmacokinetic and Pharmacodynamic Study of Kevetrin in Patients With Advanced Solid Tumors Status COMPLETED Phase PHASE1